相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hepatic fatty acid partitioning
Leanne Hodson et al.
CURRENT OPINION IN LIPIDOLOGY (2011)
Stimulation of Fat Oxidation, but no Sustained Reduction of Hepatic Lipids by Prolonged Pharmacological Inhibition of Acetyl CoA Carboxylase
M. Glien et al.
HORMONE AND METABOLIC RESEARCH (2011)
Fsp27 promotes lipid droplet growth by lipid exchange and transfer at lipid droplet contact sites
Jingyi Gong et al.
JOURNAL OF CELL BIOLOGY (2011)
Antisense oligonucleotide reduction of apoB-ameliorated atherosclerosis in LDL receptor-deficient mice
Adam E. Mullick et al.
JOURNAL OF LIPID RESEARCH (2011)
Mechanisms of single-stranded phosphorothioate modified antisense oligonucleotide accumulation in hepatocytes
Erich Koller et al.
NUCLEIC ACIDS RESEARCH (2011)
FSP27 Promotes Lipid Droplet Clustering and Then Fusion to Regulate Triglyceride Accumulation
Srikarthika Jambunathan et al.
PLOS ONE (2011)
Nonsynonymous Mutations within APOB in Human Familial Hypobetalipoproteinemia EVIDENCE FOR FEEDBACK INHIBITION OF LIPOGENESIS AND POSTENDOPLASMIC RETICULUM DEGRADATION OF APOLIPOPROTEIN B
Shumei Zhong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Bezafibrate Mildly Stimulates Ketogenesis and Fatty Acid Metabolism in Hypertriglyceridemic Subjects
Jennifer Tremblay-Mercier et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Hepatic steatosis in leptin-deficient mice is promoted by the PPARγ target gene Fsp27
Kimihiko Matsusue et al.
CELL METABOLISM (2008)
FSP27 contributes to efficient energy storage in murine white adipocytes by promoting the formation of unilocular lipid droplets
Naonobu Nishino et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Hepatic stearoyl-CoA desaturase-1 deficiency protects mice from carbohydrate-induced adiposity and hepatic steatosis
Makoto Miyazaki et al.
CELL METABOLISM (2007)
New targets and emerging therapies for reducing LDL cholesterol
Scott M. Lilly et al.
CURRENT OPINION IN LIPIDOLOGY (2007)
The safety of statins in clinical practice
Jane Armitage
LANCET (2007)
Antisense apolipoprotein B therapy: where do we stand?
Fatima Akdim et al.
CURRENT OPINION IN LIPIDOLOGY (2007)
Low-density lipoprotein cholesterol reduction: The end is more important than the means
John C. LaRosa
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Cross-species pharmacokinetic comparison from mouse to man of a second-generation antisense oligonucleotide, ISIS 301012, targeting human apolipoprotein B-100
Rosie Z. Yu et al.
DRUG METABOLISM AND DISPOSITION (2007)
Aberrant hepatic expression of PPARγ2 stimulates hepatic lipogenesis in a mouse model of obesity, insulin resistance, dyslipidemia, and hepatic steatosis
Yuan-Li Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Cholesterol absorption inhibitors as a therapeutic option for hypercholesterolaemia
John R. Burnett et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2006)
Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2
DB Savage et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins
C Baigent et al.
LANCET (2005)
Transfer of cholesteryl esters and phospholipids as well as net deposition by microsomal triglyceride transfer protein
P Rava et al.
JOURNAL OF LIPID RESEARCH (2005)
An apolipoprotein B antisense oligonucleotide lowers LDL cholesterol in hyperlipidemic mice without causing hepatic steatosis
RM Crooke et al.
JOURNAL OF LIPID RESEARCH (2005)
Molecular mediators of hepatic steatosis and liver injury
JD Browning et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Plasma cholesteryl esters provided by lecithin:cholesterol acyltransferase and acyl-coenzyme A:: Cholesterol acyltransferase 2 have opposite atherosclerotic potential
RG Lee et al.
CIRCULATION RESEARCH (2004)
Measurement of intestinal cholesterol absorption by plasma and fecal dual-isotope ratio, mass balance, and lymph fistula methods in the mouse: an analysis of direct versus indirect methodologies
DQH Wang et al.
JOURNAL OF LIPID RESEARCH (2003)
Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor γ1 (PPARγ1) overexpression
ST Yu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Regulation of fatty acid synthesis and oxidation by the AMP-activated protein kinase
DG Hardie et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2002)
The lower the better? Reviewing the evidence for more aggressive cholesterol reduction and goal attainment
E Stein
ATHEROSCLEROSIS SUPPLEMENTS (2002)
Hepatic fatty acid synthesis is suppressed in mice with fatty livers due to targeted apolipoprotein B38.9 mutation
X Lin et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Very-low-density lipoprotein assembly and secretion
GS Shelness et al.
CURRENT OPINION IN LIPIDOLOGY (2001)
A deficiency of microsomal triglyceride transfer protein reduces apolipoprotein B secretion
GK Leung et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
